Education
About Us
Working with TipRanks
Follow Us
TRACON Pharmaceuticals, Inc. (TCON)
:TCON
RESEARCH TOOLSreports
TCON Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
TRACON Pharmaceuticals News
PremiumCompany Announcements
TRACON Pharmaceuticals Initiates Wind-Down and Leadership Changes
PremiumCompany Announcements
TRACON Pharmaceuticals Announces Executive Officer Resignation
Options Prices
Currently, No data available
---
Ownership Overview
― Insiders
<0.01% Mutual Funds
― Other Institutional Investors
99.99% Public Companies and
Individual Investors
TCON FAQ
What was TRACON Pharmaceuticals, Inc.’s price range in the past 12 months?
Currently, no data Available
What is TRACON Pharmaceuticals, Inc.’s market cap?
Currently, no data Available
When is TRACON Pharmaceuticals, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were TRACON Pharmaceuticals, Inc.’s earnings last quarter?
Currently, no data Available
Is TRACON Pharmaceuticals, Inc. overvalued?
According to Wall Street analysts TRACON Pharmaceuticals, Inc.’s price is currently Undervalued.
Does TRACON Pharmaceuticals, Inc. pay dividends?
TRACON Pharmaceuticals, Inc. does not currently pay dividends.
What is TRACON Pharmaceuticals, Inc.’s EPS estimate?
TRACON Pharmaceuticals, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TRACON Pharmaceuticals, Inc. have?
Currently, no data Available
What happened to TRACON Pharmaceuticals, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of TRACON Pharmaceuticals, Inc.?
Currently, no hedge funds are holding shares in TCON
Company Description
TRACON Pharmaceuticals, Inc.
TRACON Pharmaceuticals (TCON) is a biopharmaceutical company focused on the development and commercialization of targeted therapies for cancer and other diseases. The company operates primarily in the biotechnology sector and is dedicated to developing a robust pipeline of clinical-stage product candidates. Its core products include investigational drugs designed to address unmet medical needs in oncology.
Oncternal Therapeutics
―
Alaunos Therapeutics
―
Phio Pharmaceuticals
―
Adaptimmune Therapeutics
―
ESSA Pharma
―
TFF Pharmaceuticals
―